Strides Pharma Science (Strides) on Friday said it has entered into a binding agreement with Rxilient Biohub for the sale of its manufacturing facility in Singapore for $15m.Proceeds from ...
Strides Pharma Science on Monday said it has entered into a binding agreement to sell biologics Unit-3 manufacturing facility of its associate company Stelis Biopharma (SBL) to Syngene International ...